Improved cancer therapy and molecular imaging with multivalent, multispecific antibodies.
about
Development trends for generation of single-chain antibody fragments.A method to predict response of cell populations to cocktails of chemotherapeutics and radiopharmaceuticals: validation with daunomycin, doxorubicin, and the alpha particle emitter (210)Po.Molecular imaging: challenges of bringing imaging of intracellular targets into common clinical use.Pretargeted molecular imaging and radioimmunotherapy.Bioorthogonal chemistry: implications for pretargeted nuclear (PET/SPECT) imaging and therapy.Current progress in innovative engineered antibodies.Prospective of 68Ga Radionuclide Contribution to the Development of Imaging Agents for Infection and Inflammation.
P2860
Q35216785-39D52CFC-1EC7-4A3B-B633-75B47557E6D3Q36103417-8A9DA683-C00C-4B3D-BA2B-A212D88FA52EQ37985658-76732E77-DDF2-4C19-A642-FC5F69EDAA91Q38022016-FB9AC0B3-F289-4286-9870-8CB3B159A003Q38206206-D59DFA40-4FD2-41CD-AB8D-B84FCAF1F071Q40077818-D663923F-1669-40B8-917B-1537685F485EQ54257268-4CB8D53C-C9C5-497E-81ED-8555C339BC73
P2860
Improved cancer therapy and molecular imaging with multivalent, multispecific antibodies.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Improved cancer therapy and molecular imaging with multivalent, multispecific antibodies.
@en
type
label
Improved cancer therapy and molecular imaging with multivalent, multispecific antibodies.
@en
prefLabel
Improved cancer therapy and molecular imaging with multivalent, multispecific antibodies.
@en
P2093
P2860
P356
P1476
Improved cancer therapy and molecular imaging with multivalent, multispecific antibodies.
@en
P2093
Chien-Hsing Chang
David M Goldenberg
Edmund A Rossi
Robert M Sharkey
P2860
P356
10.1089/CBR.2009.0690
P577
2010-02-01T00:00:00Z